Moonray Healthcare, the biomedical investment arm of Fidelity International, has added 10 ophthalmology centres to its network with the planned acquisition of Lexum from CEE specialist private equity house ARX Equity Investments. This follows the purchase of two centres in southern Germany from pan-Nordic player Memira, taking its network there to seven centres. We talk to Moonray CEO Tim Clover about the deal, and how Optegra grew like-for-like sales 35% in 2012 through presbyopia treatments.